Coherus BioSciences (CHRS) Reports Q2 Loss of $1.56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Form 10-Q Coherus BioSciences, For: Jun 30
August 10, 2015 5:37 PM EDThttp://archive.fast-edgar.com/20150810/A3ASAG2CZ2228Z6Y222M2ZZ2PPUDZY22Z272 Filed on: August 10, 2015... More
Form 8-K Coherus BioSciences, For: Aug 06
August 10, 2015 4:13 PM EDTUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
... More